Company Information
Industry 制造业
Company Introduction 中源协和细胞基因工程股份有限公司是一家生物科技类公司.公司主要从事生命科学技术开发、干细胞基因工程产业化、生物医疗和基因制药、纺织、印染、服装等业务.作为我国唯一的干细胞产业化基地,公司拥有全国仅两张的干细胞库许可证;同时公司也拥有亚洲最大的脐带血造血干细胞库,是亚洲脐血库组织的首批成员.公司"望春花"系列平绒产品在国内外市场品牌优势突出,是公司收入的重要贡献者。
Main Business “精准预防”领域的细胞检测制备及存储;“精准诊断”领域的体外诊断原料、体外诊断试剂和器械的研产销,生物基因、蛋白、抗体等科研试剂产品,以及基因检测服务;“细胞治疗”领域的干细胞、免疫细胞临床应用的研发等;形成“精准医疗”产业链。
Legal Representative 王洪琦
Top Executives
董事长:龚虹嘉
副董事长:王勇,王洪琦
董事:龚虹嘉,李海滨,王勇,吴珊,李旭
独立董事:侯欣一,罗明生,裴端卿
Top 5 Shareholder
Shareholder name Nature Holding Date
天津德源健康管理有限公司流通A股12.14%30/06/2024
深圳嘉道成功投资企业(有限合伙)流通A股9.60%30/06/2024
香港中央结算有限公司流通A股3.51%30/06/2024
王辉流通A股1.37%30/06/2024
北京银宏春晖投资管理有限公司流通A股1.23%30/06/2024
Company Secretary 杨新喆
Solicitors 北京国枫律师事务所
Auditors 瑞华会计师事务所(特殊普通合伙)
Tel No 022-58617160
Fax No 022-58617161
Website www.vcanbio.com
Email zhongyuanxiehe@vcanbio.com
Company Address
Register: 天津市滨海高新区华苑产业区梅苑路12号【A】座二层房屋
Office: 天津市南开区华苑产业园区梅苑路12号
Listing Date 04/05/1993
Shares Capital
Shares Capital: 467,948,890
Total A Share: 467,948,890
Listed A Share: 467,770,165
Non-tradable A Share: 178,725
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.230
DPS(RMB)* --
NBV Per Share(RMB)* ¥ 7.873
Market Capitalization(RMB) 8.443B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.